Pelthos Therapeutics Inc. (PTHS)

NYSEAMERICAN: PTHS · Real-Time Price · USD
20.39
+1.43 (7.54%)
Aug 15, 2025, 12:32 PM - Market open
7.54%
Market Cap13.45M
Revenue (ttm)n/a
Net Income (ttm)-9.04M
Shares Out 659.59K
EPS (ttm)-14.84
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume23,421
Open18.95
Previous Close18.96
Day's Range18.95 - 21.49
52-Week Range4.50 - 54.29
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2025

About PTHS

Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durh... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 11
Stock Exchange NYSEAMERICAN
Ticker Symbol PTHS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.